Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
Growth hormone to improve short bowel syndrome intestinal autonomy: a pediatric randomized open-label clinical trial

Original article by: N Peretti, I Loras-Duclaux, B Kassai, et al.

Reference: Journal of Parenteral and Enteral Nutrition Nov 2011;35(6):723-731

Source: Journal of Parenteral and Enteral Nutrition

Keywords: Child; Growth Hormone; Parenteral Feeding; Short Bowel Syndrome; Intestinal Diseases; Intestinal Failure; Paediatrics;

Date published: 16/12/2011 16:08

Summary
by: Judith Lambert

The ability of growth hormone (GH) to promote the weaning off of parenteral nutrition (PN) in short bowel syndrome (SBS) is unclear.  No randomised controlled study is available in children.  This study was undertaken to determine if GH could enhance the weaning off of PN in PN-dependent children with SBS.  GH did not improve the weaning off of PN in PN-dependent children with SBS. (40 refs.)

About this library entry
Category: Small intestine
NeLM area:  Evidence > Medicines Management > References
Abstract link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back